Skip to content

Napp Pharmaceuticals Limited Website Cookie Policy

Our Cookie Policy page outlines what cookies the napp.test website uses and gives you guidance on how to manage your cookie settings. By continuing to browse the site you are giving your consent to our use of cookies. Please read the below for more information.

What are cookies?

Cookies are small text files that websites use to enhance a website’s functionality as well as gathering information about a user’s movements around the site. Unless they are essential to the operation of the site, websites must now ask users to give their consent for cookies to be stored on their computers. If a website user consents to enable cookies on a website, then these small text files are placed on the user’s computer hard drive. The information these cookies contain can then be used by the website server whenever the user visits the site. Essentially, cookies allow a website to remember their users, which makes the interaction between user and website faster and easier. Not allowing cookies might impact on how efficiently a user can browse the website.

What cookies does the napp.test website use and why?

There are different types of cookies that do different things. We use various types of cookies to optimise the user experience, which you can read about in the table below. Please remember that disabling cookies might have an impact on how you are able to use the napp.test site. You can read more about this under the ‘What happens if I disable cookies?’ question further down this page. 


What does it do and why do we use it?



This cookie confirms that you have given your consent to the use of cookies on our site and stops the pop-up message from displaying on your screen on future visits.


This site complies with the DDA to allow people to resize the font across the site. This cookie stores the value of the font size you have selected and saves it while you surf the website. This means that all the pages you visit will display in the same font size and you will not need to re-select the font size if you move to another page.


This website is available in a different format to allow it to be used optimally on a smart phone. This cookie overrides the mobile site and delivers the full version of the website to mobile devices if the user selects this option.


These cookies are from Google Analytics. We use these cookies to measure the user experience of our website, e.g. how many times and how long a user visits our website. This information is anonymous and we use it to help us continue to develop our site to improve your experience.

What happens if I disable cookies on the napp.test website? Will the site still work?

The napp.test website will still work, although depending on the cookies the website uses, some features and functionalities of the website might be affected if you withdraw your consent. Disabling cookies means that we will be unable to track your usage, which affects the extent to which we can develop and improve our website. Cookies which allow us to anonymously store your information and track your movements around the site provide valuable insights into how you like to use the napp.test website. Based on this information, we can work to improve your experience.

What if I change my mind and want to withdraw my consent at a later date?

You can change your cookie settings at any time. Depending on which internet browser you use, the means by which you change your cookie settings will vary. provides browser-specific directions to help you do this. Please be aware that if you do choose to disable some or all cookies for the napp.test website then you may lose some features and functionality of the site.


The European Commission is reviewing the E-Privacy Directive, implemented in the UK by the Privacy and Electronic Communications Regulations 2003/2426 (as amended) (PECR). The replacement, the draft E-Privacy Regulation (COM (2017) 10 final) (ePR), was not agreed in time to align with the coming into force of the GDPR on 25 May 2018. The UK Information Commissioner’s Office (ICO) has confirmed that PECR (with GDPR standard of consent) will continue to apply until the ePR is finalised. The ICO will be publishing updated guidance on cookies to reflect the GDPR and PECR and we will update this Cookie Notice once the ICO has issued further guidance.

Last updated 25 May 2018


Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”